Endothelial progenitor cells (EPCs) are mononuclear cells that circulate in the blood and are
derived from different tissues, expressing cell surface markers that are similar to mature …

Age is a significant risk factor for the development of vascular diseases, such as
atherosclerosis. Although pharmacological treatments, including statins and anti …

Age represents a significant risk factor for the onset and progression of cardiovascular
disease, with the increase in life expectancy in developed countries going in parallel with …

Endothelial dysfunction is associated with major causes of morbidity and mortality, as well
as numerous age-related conditions. The possibility of preserving or even rejuvenating …

Endothelial progenitor cells (EPCs) are involved in the maintenance of endothelial
homoeostasis and in the process of new vessel formation. Experimental and clinical studies …

Endothelial dysfunction, which is considered the functional equivalent of a disrupted
balance between endothelial injury and repair, precedes overt atherosclerosis by many …

Endothelial dysfunction has been associated with the development of atherosclerosis and
cardiovascular diseases. Adult endothelial progenitor cells (EPCs) are derived from …

Circulating endothelial progenitor cells (EPCs), are believed to be home to sites of
neovascularization, contributing to vascular regeneration either directly via incorporation …

Abstract The concept of Endothelial Progenitor Cells (EPCs) therapy for adult
neovascularization has continuously received attention. They are believed to participate in …

The integrity and functional activity of the endothelial monolayer play a critical role in
preventing atherosclerotic disease progression. Endothelial cell (EC) damage by …